Browsing Category
Healthcare Industry News
2467 posts
Anterior raises $40m to scale payer workflow automation as healthcare AI shifts from pilots to production
Anterior Inc. secures $40 million to expand health plan AI deployment. Discover what this signals for payer automation, investors, and the future of healthcare workflows.
February 12, 2026
What Galderma’s Japan launch of Restylane Defyne and Refyne means for the Asia aesthetics market
Galderma launches Restylane Defyne and Refyne in Japan, expanding OBT injectables. Find out what this means for Asia growth and investors.
February 11, 2026
Can Harbor Health’s Rippl deal redefine dementia care economics in Texas and beyond?
Harbor Health acquires Rippl to expand dementia care and strengthen its pay-vider model. Discover what this means for Texas healthcare markets.
February 11, 2026
CIMG Inc acquisition of Daren Business Technology signals a strategic pivot toward biopharmaceutical scale ambitions
CIMG Inc is entering biopharmaceuticals with a $40 million, performance-linked acquisition. Find out what this deal means for strategy, risk, and investors.
February 11, 2026
VolitionRx Limited faces NYSE compliance deadline tied to sustained sub-US$1 share price
VolitionRx Limited receives a NYSE non-compliance notice tied to its share price. Find out what it means for investors, strategy, and what comes next.
February 10, 2026
Innocan Pharma reports placebo-controlled clinical evidence supporting long-acting LPT-CBD for canine osteoarthritis pain
Innocan Pharma Corporation publishes placebo-controlled clinical data supporting long-acting LPT-CBD for osteoarthritis pain. Find out what it means for non-opioid pain markets.
February 10, 2026
Why Clalit Health Services’ vendor approval changes the commercialization math for Inspira Technologies’ ART100 system (NASDAQ: IINN)
Find out how Clalit Health Services’ vendor approval could accelerate Inspira Technologies’ ART100 deployment and reshape its commercialization trajectory.
February 9, 2026
Neurophet bags third FDA 510(k) clearance as AI imaging tools move closer to frontline Alzheimer’s care decisions
Neurophet wins FDA clearance for AQUA AD Plus, strengthening its U.S. strategy as AI imaging becomes central to Alzheimer’s treatment decisions. Read more.
February 9, 2026
Is Encompass Health quietly building the most predictable growth model in post acute care
Encompass Health Corporation targets up to $6.465 billion in 2026 revenue. Find out what this outlook means for rehabilitation care and investors.
February 7, 2026
Field Medical Field PULSE data signals next phase of pulsed field ablation platform competition
Discover why Field Medical’s Field PULSE trial could reshape pulsed field ablation strategy as focal PFA challenges single-shot dominance.
February 6, 2026